IEXIdex Corporation

Upcoming Earnings

We were not able to find an announced earnings date for this symbol yet. Check back again later

Company Info

CEO

Eric D. Ashleman

Location

Illinois, USA

Exchange

NYSE

Website

https://idexcorp.com

Summary

IDEX Corporation provides applied solutions worldwide.

Company Info

CEO

Eric D. Ashleman

Location

Illinois, USA

Exchange

NYSE

Website

https://idexcorp.com

Summary

IDEX Corporation provides applied solutions worldwide.

AI Insights for IEX
6 min read

Quick Summary

IDEX Corporation is a diversified industrial technology company that provides applied solutions for fluidics, metering, health science, fire safety, and other specialized industrial applications. The company operates through Fluid & Metering Technologies, Health & Science Technologies, and Fire & Safety/Diversified Products. It sells engineered pumps, valves, flow meters, dispensing systems, filtration components, rescue tools, firefighting equipment, and precision components used in mission-critical environments. Its customers include industrial manufacturers, life-science and medical technology companies, semiconductor and analytical instrument makers, municipal and emergency response agencies, energy companies, food and beverage producers, and transportation-related businesses. IDEX’s model is built around niche markets where customers need reliable, highly engineered products rather than commodity equipment. The company is headquartered in Illinois, led by CEO Eric D. Ashleman, and trades on the NYSE under the symbol IEX.

Strengths

•

IDEX’s primary strength is its portfolio of highly specialized businesses serving niche markets with mission-critical engineered products.

•

The company has strong positions in fluid handling, precision metering, filtration, rescue tools, and health science components.

•

These markets often have high switching costs because customers value reliability, technical performance, and product qualification history.

•

IDEX also benefits from strong profitability, with Moody’s noting expected EBITDA margins around 28% and robust free cash flow generation.

•

Its diversified exposure across industrial, healthcare, science, safety, municipal, and technology markets reduces dependence on any single customer group.

Key Risks

•

IDEX faces risks from industrial cyclicality, customer destocking, slower capital spending, and weakness in manufacturing activity.

•

Supply-chain disruptions, labor shortages, and inflation can pressure margins and delay customer deliveries.

•

Acquisition-related risks are important because recent and pending transactions are large enough to affect leverage, integration complexity, and management focus.

•

If Mott, Airtech Group, US Valve, or future acquisitions underperform, investors may question the company’s capital allocation discipline.

What to Watch

During the most recent reported quarter, IDEX delivered $920.6 million in revenue and $199.9 million in operating income.
Gross profit was $426.8 million, indicating continued strength in profitability and a sizable gross margin profile.
Net income was $143.4 million, while basic EPS was $1.94 and diluted EPS was $1.93.
The company continued to operate across its three main segments: Fluid & Metering Technologies, Health & Science Technologies, and Fire & Safety/Diversified Products.
Recent corporate activity also included the completed $1 billion acquisition of Mott, which expands IDEX’s Health & Science Technologies capabilities in porous metal components, filtration, flow control, semiconductors, medical technology, and water purification.
The company also announced a $470 million deal to acquire Airtech Group, US Valve, and related entities, with expected closing by the end of Q2 according to the provided news.
Moody’s affirmed IDEX’s Baa2 issuer and senior unsecured ratings with a stable outlook, citing strong niche positions, steady profitability, robust liquidity, and free cash flow expectations above $300 million.

Price Drivers

•

IDEX’s stock price is driven primarily by earnings growth, organic revenue growth, operating margins, free cash flow, and investor confidence in its acquisition strategy.

•

The most recent reported quarter showed operating revenue of $920.6 million, gross profit of $426.8 million, operating income of $199.9 million, and net income of $143.4 million.

•

Valuation is also a major factor because the shares trade at relatively premium industrial multiples, including a price-to-earnings ratio of about 32.5 and EV/EBITDA of about 18.9.

•

Investors are likely rewarding the company’s niche market positions, strong margins, and consistent cash generation, but the premium valuation means the stock can be sensitive to any slowdown.

•

Acquisitions such as Mott and the announced Airtech Group and US Valve transaction can support growth, but they also raise questions about integration, leverage, and return on invested capital.

•

Macro factors such as industrial demand, interest rates, manufacturing activity, supply-chain costs, labor inflation, and customer capital spending also influence the stock.

•

The dividend yield is modest at about 1.27%, so the stock is more growth-and-quality driven than income driven.

Recent News

•

Recent company-specific news includes IDEX’s agreement to acquire Airtech Group, US Valve, and related entities for $470 million.

•

The transaction is expected to expand IDEX’s air-moving and pressure technology offerings across medical, food, energy, transportation, and other markets.

•

IDEX also completed its $1 billion acquisition of Mott, a porous metal components maker, strengthening the Health & Science Technologies segment in filtration, flow control, semiconductors, medical technology, and water purification.

•

Moody’s affirmed IDEX’s Baa2 issuer and senior unsecured ratings with a stable outlook, citing strong niche positions, profitability, liquidity, and free cash flow.

•

The rating commentary also noted risks from supply-chain pressures, labor constraints, inflation, and acquisition-related leverage.

•

The provided news feed also contains several items about Investors Exchange and IEX Options, but those appear unrelated to IDEX Corporation despite using the same IEX name.

•

Investors should focus on IDEX Corporation’s acquisitions, segment performance, earnings, margins, and balance-sheet impacts rather than unrelated exchange-industry headlines.

Market Trends

•

Broader market trends affecting IDEX include demand for automation, precision fluid control, life-science instrumentation, medical technology, clean water systems, and specialized industrial equipment.

•

The scientific instrument market is expected to grow over the long term, supported by R&D spending, healthcare, biotechnology, pharmaceuticals, diagnostics, and automation.

•

Semiconductor manufacturing and advanced electronics also create demand for high-quality filtration and flow-control components.

•

Public safety equipment markets are supported by modernization needs, municipal replacement cycles, and growing expectations for advanced emergency response capabilities.

•

At the same time, industrial companies face pressure from inflation, labor costs, supply-chain normalization, and uncertain global manufacturing demand.

•

Higher interest rates can reduce industrial valuation multiples and make acquisition financing more expensive.

•

Companies with strong margins, recurring aftermarket demand, and defensible niches are generally better positioned in this environment, which supports IDEX’s strategic profile if execution remains strong.

AI-generated summary for educational purposes only. Not investment advice. Always do your own research before investing.

Community Research

Research from investors like you

Be the first to share your analysis on IEX

Help fellow investors make informed decisions by sharing your research on fundamentals, catalysts, and outlook.

Topics: Company overview • Products • Competitors • Strengths & Risks

Symbol's posts

No more topics to show